Related Experiment Video
Updated: May 20, 2026

12:31
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
Published on: May 1, 2018
Synthetic antibodies: concepts, potential and practical considerations
1Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, Canada. shane.miersch@utoronto.ca
Methods (San Diego, Calif.)
|July 4, 2012
Summary
Synthetic antibody libraries offer novel specificities beyond natural immune repertoires. Phage display technology enables in vitro design of antibodies for research, diagnostics, and therapeutics.
Area of Science:
- Immunology
- Biotechnology
- Molecular Biology
Background:
- Antibodies are crucial for humoral immunity, identifying and neutralizing foreign substances.
- Antibody specificity is key for research, diagnostics, and therapeutics.
- Limitations exist in developing antibodies using traditional animal-based methods.
Purpose of the Study:
- To review the convergence of technologies in developing combinatorial phage-displayed antibody libraries.
- To explore concepts of phage display, antibody diversity, and library generation/selection.
- To highlight applications of synthetic antibody libraries yielding unique specificities.
Main Methods:
- Review of technologies contributing to phage-displayed antibody libraries.
- Exploration of phage display principles and antibody diversity.
- Examination of methods for generating and selecting from synthetic antibody libraries.
Main Results:
- Synthetic antibody libraries provide diversity beyond natural immune repertoires.
- Phage display enables in vitro antibody design with tailored specificities.
- Design approaches yield specificities unattainable with natural libraries.
Conclusions:
- Phage-displayed synthetic antibody libraries represent a significant advancement in antibody engineering.
- These libraries overcome limitations of traditional antibody development.
- They offer powerful tools for research, diagnostics, and therapeutic applications.
Related Concept Videos
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Cross-reactivity
Overview
Antibody Structure and Classes
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Affinity and Avidity
Overview

